BLI-1006

N/A

Report date: 2025/01/26 16:40:25

NME

Base Information

Drug NameBLI-1006

Drug Alias NameBLI-1006

ClassificationNatural product/ExtractSmall molecules

Mechanisms of ActionCytokine receptors antagonists

TargetsCytokine receptorsInterleukin 18 receptor

Therapy Area/IndicationsInflammatory Bowel Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesEuropeTaiwan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBiolite Inc

China Registration ClassN/A

Active CompaniesBiolite Inc

Inactive CompaniesN/A

Active IndicationsInflammatory Bowel Diseases

Inactive IndicationsN/A

ATC CodeN/A